While few studies have shown contradictory results, it is generally well accepted that obesity and metabolic changes occurring with the development of T2D are associated with a decline in the postprandial secretion of GLP-1 from L-cells [78–83]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.